(Q58827996)

English

Two-Months-off, Four-Months-on Antiretroviral Regimen Increases the Risk of Resistance, Compared with Continuous Therapy: A Randomized Trial Involving West African Adults

scientific article published on 01 January 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18986246%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Two-months-off, four-months-on antiretroviral regimen increases the risk of resistance, compared with continuous therapy: a randomized trial involving West African adults (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18986246%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Christine Rouzioux

9

object named as

Christine Rouzioux

0 references

2

object named as

Raoul Moh

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18986246%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Delphine Gabillard

4

object named as

Delphine Gabillard

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18986246%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Xavier Anglaret

12

object named as

Xavier Anglaret

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18986246%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Christine Danel

1

object named as

Christine Danel

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18986246%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

author name string

Marie-Laure Chaix

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18986246%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Joachim Gnokoro

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18986246%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Charles-Joseph Diby

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18986246%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Thomas Toni

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18986246%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Lambert Dohoun

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18986246%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Emmanuel Bissagnene

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18986246%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Roger Salamon

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18986246%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Christine Rouzioux

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18986246%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Trivacan ANRS 1269 Trial Group

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18986246%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

language of work or name

0 references

publication date

1 January 2009

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18986246%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Journal of Infectious Diseases

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18986246%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

199

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18986246%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18986246%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

66-76

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18986246%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

The risk of treatment versus the risk of HIV replication

1 reference

https://api.crossref.org/works/10.1086%2F595298

21 January 2018

Structured Treatment Interruptions: A Risky Business

1 reference

https://api.crossref.org/works/10.1086%2F595298

21 January 2018

Antiretroviral therapy interruption guided by CD4 cell counts and plasma HIV-1 RNA levels in chronically HIV-1-infected patients.

1 reference

https://api.crossref.org/works/10.1086%2F595298

21 January 2018

CD4+ count-guided interruption of antiretroviral treatment

1 reference

https://api.crossref.org/works/10.1086%2F595298

21 January 2018

A Pilot Study Evaluating Time to CD4 T-cell Count <350 cells/mm3 After Treatment Interruption Following Antiretroviral Therapy ± Interleukin 2: Results of ACTG A5102

1 reference

https://api.crossref.org/works/10.1086%2F595298

21 January 2018

CD4-guided scheduled treatment interruptions compared with continuous therapy for patients infected with HIV-1: results of the Staccato randomised trial

1 reference

https://api.crossref.org/works/10.1086%2F595298

21 January 2018

Intermittent antiretroviral therapy in patients with controlled HIV infection

1 reference

https://api.crossref.org/works/10.1086%2F595298

21 January 2018

Platelet- and megakaryocyte-derived microparticles transfer CXCR4 receptor to CXCR4-null cells and make them susceptible to infection by X4-HIV.

1 reference

https://api.crossref.org/works/10.1086%2F595298

21 January 2018

Long-cycle structured intermittent versus continuous highly active antiretroviral therapy for the treatment of chronic infection with human immunodeficiency virus: effects on drug toxicity and on immunologic and virologic parameters

1 reference

https://api.crossref.org/works/10.1086%2F595298

21 January 2018

Randomized, controlled trial of therapy interruption in chronic HIV-1 infection

1 reference

https://api.crossref.org/works/10.1086%2F595298

21 January 2018

Fixed duration interruptions are inferior to continuous treatment in African adults starting therapy with CD4 cell counts < 200 cells/microl

1 reference

https://api.crossref.org/works/10.1086%2F595298

21 January 2018

A prospective, randomized trial of structured treatment interruption for patients with chronic HIV type 1 infection.

1 reference

https://api.crossref.org/works/10.1086%2F595298

21 January 2018

Getting smarter--the toxicity of undertreated HIV infection

1 reference

https://api.crossref.org/works/10.1086%2F595298

21 January 2018

CD4-guided structured antiretroviral treatment interruption strategy in HIV-infected adults in west Africa (Trivacan ANRS 1269 trial): a randomised trial

1 reference

https://api.crossref.org/works/10.1086%2F595298

21 January 2018

Transfer and evaluation of an automated, low-cost real-time reverse transcription-PCR test for diagnosis and monitoring of human immunodeficiency virus type 1 infection in a West African resource-limited setting

1 reference

https://api.crossref.org/works/10.1086%2F595298

21 January 2018

Stable prevalence of genotypic drug resistance mutations but increase in non-B virus among patients with primary HIV-1 infection in France

1 reference

https://api.crossref.org/works/10.1086%2F595298

21 January 2018

Random-effects models for serial observations with binary response.

1 reference

https://api.crossref.org/works/10.1086%2F595298

21 January 2018

Emergence of drug-resistant HIV-1 variants in patients undergoing structured treatment interruptions

1 reference

https://api.crossref.org/works/10.1086%2F595298

21 January 2018

Risk of selecting de novo drug-resistance mutations during structured treatment interruptions in patients with chronic HIV infection

1 reference

https://api.crossref.org/works/10.1086%2F595298

21 January 2018

Interpatient variability in the pharmacokinetics of the HIV non-nucleoside reverse transcriptase inhibitor efavirenz: the effect of gender, race, and CYP2B6 polymorphism

1 reference

https://api.crossref.org/works/10.1086%2F595298

21 January 2018

Pharmacogenetics of plasma efavirenz exposure after treatment discontinuation: an Adult AIDS Clinical Trials Group Study

1 reference

https://api.crossref.org/works/10.1086%2F595298

21 January 2018

Effects of active treatment discontinuation in patients with a CD4+ T-cell nadir greater than 350 cells/mm3: 48-week Treatment Interruption in Early Starters Netherlands Study (TRIESTAN).

1 reference

https://api.crossref.org/works/10.1086%2F595298

21 January 2018

Nevirapine clearance from plasma in African adults stopping therapy: a pharmacokinetic substudy.

1 reference

https://api.crossref.org/works/10.1086%2F595298

21 January 2018

Treatment interruptions predict resistance in HIV-positive individuals purchasing fixed-dose combination antiretroviral therapy in Kampala, Uganda

1 reference

https://api.crossref.org/works/10.1086%2F595298

21 January 2018

Identifiers

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18986246%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18986246%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q58827996&oldid=2092716232"